# The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

> **NCT02815540** · PHASE1,PHASE2 · TERMINATED · sponsor: **Gillette Children's Specialty Healthcare** · enrollment: 2 (actual)

## Conditions studied

- Lennox-Gastaut Syndrome
- Dravet Syndrome

## Interventions

- **PROCEDURE:** 12-Lead ECG
- **DRUG:** Cannabidiol

## Key facts

- **NCT ID:** NCT02815540
- **Lead sponsor:** Gillette Children's Specialty Healthcare
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-16
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Investigator no longer at institution, and difficult recruitment; study will not resume
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815540, "The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02815540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*